(NASDAQ: TSVT) 2seventy Bio's forecast annual revenue growth rate of -2.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
2seventy Bio's revenue in 2024 is $100,387,000.On average, 4 Wall Street analysts forecast TSVT's revenue for 2024 to be $5,159,693,501, with the lowest TSVT revenue forecast at $3,145,372,392, and the highest TSVT revenue forecast at $7,913,613,266. On average, 4 Wall Street analysts forecast TSVT's revenue for 2025 to be $5,994,063,818, with the lowest TSVT revenue forecast at $3,040,184,571, and the highest TSVT revenue forecast at $10,940,713,498.
In 2026, TSVT is forecast to generate $3,940,181,826 in revenue, with the lowest revenue forecast at $3,263,387,995 and the highest revenue forecast at $4,616,975,657.